NPPA fixes retail price of 19 formulations, Details Susmita Roy25 Feb 2022 3:23 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Cadila Healthcare is now Zydus Lifesciences Ruchika Sharma24 Feb 2022 6:08 PM ISTNew Delhi: The Zydus group announced its new brand identity with the listed entity of the group Cadila Healthcare Ltd. to be known as Zydus...
Novartis gets CDSCO panel okay for phase 3 trial of Secukimunab Dr. Divya Colin23 Feb 2022 3:10 PM ISTNew Delhi: The pharmaceutical major, Novartis, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Govt Hospital sets its own price cap for cardiac stents, others may soon follow Sanchari Chattopadhyay22 Feb 2022 4:53 PM ISTDelhi: Bringing relief for the patients suffering from heart attack and blockage in the arteries of the heart, GB Pant Hospital has made it possible...
Intas pharma gets CDSCO panel nod to manufacture, market schizophrenia drug Clozapine Susmita Roy21 Feb 2022 5:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharmaceuticals has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Submit in vitro data on safety of Ropivacaine HCL monohydrate delivery: CDSCO panel tells Cipla Dr. Divya Colin20 Feb 2022 12:30 PM ISTNew Delhi: In line with the pharma major Cipla's Phase III clinical trial data for the local anaesthetic drug Ropivacaine HCL monohydrate solution for...
Novartis Healthcare gets CDSCO panel nod to market anti cancer drug Dabrafenib Susmita Roy19 Feb 2022 5:49 PM ISTNew Delhi: In a significant development, pharmaceutical major Novartis Healthcare has got a go ahead from the Subject Expert Committee (SEC) of the...
Serdia Pharma gets CDSCO nod for anti-diabetic FDC of extended-release Gliclazide 60mg plus Metformin 1000mg tablet Susmita Roy18 Feb 2022 1:34 PM ISTNew Delhi: In a significant development, Serdia® Pharmaceuticals (India) Pvt. Ltd. has got approval from the Central Drugs Standard Control...
Sun Pharma gets CDSCO nod to market Tofacitinib to treat Rheumatoid Arthritis, Psoriatic Arthritis, Ulcerative Colitis Susmita Roy17 Feb 2022 4:20 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Dr Reddys to sell two brands, Combihal and Daffy to Mankind Pharma Ruchika Sharma16 Feb 2022 5:34 PM ISTThe entire integration and transition of the brands is expected to be completed by March 2022.
Submit revised protocol for Ticagrelor SR tablets: CDSCO panel tells MSN Labs Susmita Roy15 Feb 2022 5:44 PM ISTNew Delhi: Opining that the Phase III clinical trial protocol presented by the drug maker MSN Laboratories was inadequate with respect to...
Drug Alert: CDSCO flags 27 formulations as not of standard quality Susmita Roy14 Feb 2022 5:17 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 27 medicine...
